AU2005215114B2 - Use of factor XIII for stimulating the perfusion of ischemic tissue - Google Patents

Use of factor XIII for stimulating the perfusion of ischemic tissue Download PDF

Info

Publication number
AU2005215114B2
AU2005215114B2 AU2005215114A AU2005215114A AU2005215114B2 AU 2005215114 B2 AU2005215114 B2 AU 2005215114B2 AU 2005215114 A AU2005215114 A AU 2005215114A AU 2005215114 A AU2005215114 A AU 2005215114A AU 2005215114 B2 AU2005215114 B2 AU 2005215114B2
Authority
AU
Australia
Prior art keywords
fxiiia
preparation
treatment
fxiii
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005215114A
Other languages
English (en)
Other versions
AU2005215114A1 (en
Inventor
Rima Dardik
Gerhard Dickneite
Aida Inbal
Jonathan Leor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
CSL Behring GmbH Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Behring GmbH Deutschland filed Critical CSL Behring GmbH Deutschland
Publication of AU2005215114A1 publication Critical patent/AU2005215114A1/en
Assigned to CSL BEHRING GMBH reassignment CSL BEHRING GMBH Request for Assignment Assignors: ZLB BEHRING GMBH
Application granted granted Critical
Publication of AU2005215114B2 publication Critical patent/AU2005215114B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2005215114A 2004-02-20 2005-02-15 Use of factor XIII for stimulating the perfusion of ischemic tissue Ceased AU2005215114B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04003950.5 2004-02-20
EP04003950A EP1566183A1 (en) 2004-02-20 2004-02-20 Use of factor XIII for stimulating the perfusion of ischemic tissue
PCT/EP2005/001495 WO2005079839A1 (en) 2004-02-20 2005-02-15 Use of factor xiii for stimulating the perfusion of ischemic tissue

Publications (2)

Publication Number Publication Date
AU2005215114A1 AU2005215114A1 (en) 2005-09-01
AU2005215114B2 true AU2005215114B2 (en) 2010-05-20

Family

ID=34707356

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005215114A Ceased AU2005215114B2 (en) 2004-02-20 2005-02-15 Use of factor XIII for stimulating the perfusion of ischemic tissue

Country Status (11)

Country Link
US (1) US20070167361A1 (https=)
EP (2) EP1566183A1 (https=)
JP (1) JP2007523111A (https=)
KR (1) KR20060123567A (https=)
AT (1) ATE429244T1 (https=)
AU (1) AU2005215114B2 (https=)
CA (1) CA2556805C (https=)
DE (1) DE602005014085D1 (https=)
DK (1) DK1718328T3 (https=)
ES (1) ES2325996T3 (https=)
WO (1) WO2005079839A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20130532A1 (it) * 2013-06-27 2014-12-28 Donato Gemmati Nuovo biomarcatore prognostico nell'infarto acuto del miocardio

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022470A1 (en) * 1993-03-30 1994-10-13 Hoechst Japan Limited Factor xiii for treatment of skin wounds
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572168B1 (en) * 2002-02-06 2010-05-26 Vicor Technologies, Inc. Anti-infarction molecules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022470A1 (en) * 1993-03-30 1994-10-13 Hoechst Japan Limited Factor xiii for treatment of skin wounds
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DARDIK RIMA et al. Arteriosclerosis, Thrombosis and Vascular Biology. 2003. 23: 1472-1477 *

Also Published As

Publication number Publication date
ATE429244T1 (de) 2009-05-15
CA2556805C (en) 2013-04-02
KR20060123567A (ko) 2006-12-01
EP1718328A1 (en) 2006-11-08
EP1566183A1 (en) 2005-08-24
DK1718328T3 (da) 2009-07-27
WO2005079839A1 (en) 2005-09-01
DE602005014085D1 (de) 2009-06-04
US20070167361A1 (en) 2007-07-19
EP1718328B1 (en) 2009-04-22
ES2325996T3 (es) 2009-09-28
JP2007523111A (ja) 2007-08-16
AU2005215114A1 (en) 2005-09-01
CA2556805A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
US8377881B2 (en) Compositions and methods for reducing scar formation in wound healing
US20070093748A1 (en) Methods and systems for treating injured cardiac tissue
AU2003255290A1 (en) Use of erythropoietin
ES2477498T3 (es) Proteína 4 del tipo angiopoyetina (ANGPTL4) para el mantenimiento de la integridad de la barrera celular del endotelio vascular
KR20090092325A (ko) Ｆｖⅲ 농축물을 포함하는 프로트롬빈 복합물 농축물의 상승적 치료 용도
TW200829267A (en) Method of treating endothelial dysfunction
US5364622A (en) Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
JP5400006B2 (ja) 虚血性疾患の予防または治療剤
ES2251953T3 (es) Uso de desmopresina en la preparacion de un medicamento inhibidor de la diseminacion metastasica durante la cirugia del cancer.
US5578305A (en) Methods and preparations for preventing adhesions to organs and parts of organs
AU2005215114B2 (en) Use of factor XIII for stimulating the perfusion of ischemic tissue
KR19990087825A (ko) 조직 인자 응고계 억제제 함유 혈관 신생 저해제
US8263756B2 (en) Method of gene transfer via vascular system or ureter
US8106009B2 (en) Pharmaceutical composition for preventing or treating ischemic diseases
US20250295741A1 (en) Prevention of post-operative atrial fibrillation with a botulinum toxin
RU2729788C2 (ru) Средство, его применение и способ повышения устойчивости организма млекопитающих к ишемически-реперфузионному поражению тонкого кишечника
CN119454907A (zh) Vegf-c156s在制备减轻静脉移植物狭窄的药物中的应用
JPH08268910A (ja) プロテインｃの皮下投与のための薬剤
JPWO1999016463A1 (ja) 虚血性疾患の予防または治療剤
US20030087825A1 (en) Method for inhibiting the formation of seromas using factor XIII
EP1912594A2 (en) Methods and systems for treating injured cardiac tissue
HK1031820A (en) Use of desmopressin in the preparation of a metastatic dissemination inhibitor medicament during cancer surgery

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: CSL BEHRING GMBH

Free format text: FORMER NAME: ZLB BEHRING GMBH

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired